This week in charts: ESMO’s winners and losers
BioPharma DiveJonathan GardnerOctober 30, 2026
The latest installment in BioPharma Dive s visualization-focused series looks at Wall Street s response to a trio of closely watched presentations at a top meeting for cancer drugs.